Vistagen CEO granted options for 75K shares
Vistagen Therapeutics reported that President and CEO Shawn Singh received grants of incentive and non-qualified stock options covering a total of 75,000 shares of common stock at an exercise price of $0.5358 per share.
Rhea-AI Filing Summary
Vistagen Therapeutics reported that President and CEO Shawn Singh received grants of incentive and non-qualified stock options covering a total of 75,000 shares of common stock at an exercise price of $0.5358 per share. According to the grant terms, 25% of the options will vest on the six-month anniversary of April 7, 2026, with additional 25% installments vesting every six months until they are fully vested on the two-year anniversary of the grant date. The options expire on April 7, 2036.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 75,000 shares
Grant/Award
2 txns
Insider
Singh Shawn
Role
President and CEO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Incentive Stock Option (right to buy) | 3,732 | $0.00 | $0.00 |
| Grant/Award | Non-Qualified Stock Option (right to buy) | 71,268 | $0.00 | $0.00 |
Holdings After Transaction:
Incentive Stock Option (right to buy) — 3,732 contracts (Direct);
Non-Qualified Stock Option (right to buy) — 71,268 contracts (Direct)
Footnotes (1)
- F1. Represents stock options (the "Options") granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended. 25% of the Options will vest on the six-month anniversary of April 7, 2026 (the "Grant Date"), and will vest in 25% installments every six months thereafter until the Options become fully vested on the two (2) year anniversary of the Grant Date.
Key Figures
Incentive Stock Options granted: 3,732 options
Non-Qualified Stock Options granted: 71,268 options
Total options underlying shares: 75,000 shares
+4 more
7 metrics
Incentive Stock Options granted
3,732 options
Grant to CEO Shawn Singh on April 7, 2026
Non-Qualified Stock Options granted
71,268 options
Grant to CEO Shawn Singh on April 7, 2026
Total options underlying shares
75,000 shares
Combined incentive and non-qualified options granted
Option exercise price
$0.5358 per share
Strike price for both new option grants
Option expiration date
April 7, 2036
End of exercise period for granted options
Initial vesting milestone
25% of options
Vest on six-month anniversary of April 7, 2026
Full vesting period
2 years from grant date
Options fully vest by two-year anniversary of April 7, 2026
Key Terms
Incentive Stock Option, Non-Qualified Stock Option, Amended and Restated 2019 Omnibus Equity Incentive Plan, vest, +1 more
5 terms
Incentive Stock Option financial
"Incentive Stock Option (right to buy)"
An incentive stock option is a type of employee benefit that gives a worker the right to buy company shares at a fixed price, with special tax advantages if the employee holds the shares for a required period. Think of it as a coupon to buy future shares at today’s price that can result in lower tax on the gain. Investors care because ISOs can dilute share count, align staff incentives with the stock price, and affect company compensation costs and the timing of potential share sales.
Non-Qualified Stock Option financial
"Non-Qualified Stock Option (right to buy)"
A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.
Amended and Restated 2019 Omnibus Equity Incentive Plan financial
"granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan"
vest financial
"25% of the Options will vest on the six-month anniversary"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
Grant Date financial
"until the Options become fully vested on the two (2) year anniversary of the Grant Date"
The grant date is the day a company formally gives an employee or contractor the right to receive stock-based compensation, such as stock options or restricted shares. It matters to investors because it fixes key terms—like the price, the start of the ownership clock, and when the award will affect the company’s financial statements and share count—so it can influence dilution, reported expenses, and potential future selling pressure.
FAQ
What did Vistagen (VTGN) disclose about Shawn Singh’s latest equity grant?
Vistagen disclosed that President and CEO Shawn Singh received grants of incentive and non-qualified stock options for 75,000 common shares. These options represent compensation awards, not open-market purchases, and give him the right to buy shares at a fixed exercise price in the future.
What is the exercise price of the new Vistagen (VTGN) CEO stock options?
The newly granted stock options to Vistagen CEO Shawn Singh carry an exercise price of $0.5358 per share. This strike price is the amount he must pay per share if he chooses to exercise the options before they expire in April 2036.
How do the vesting terms work for Shawn Singh’s new VTGN options?
The options vest over two years, with 25% vesting on the six-month anniversary of April 7, 2026. The remaining 75% vest in additional 25% installments every six months, so the grant is fully vested on the two-year anniversary of the grant date.
What types of stock options were granted to the Vistagen (VTGN) CEO?
Shawn Singh received two types of derivative awards: Incentive Stock Options and Non-Qualified Stock Options. Together they cover 75,000 underlying common shares and were granted under Vistagen’s Amended and Restated 2019 Omnibus Equity Incentive Plan as amended.
When do Shawn Singh’s newly granted Vistagen (VTGN) options expire?
Both the incentive and non-qualified stock options granted to Shawn Singh on April 7, 2026 expire on April 7, 2036. He must exercise any vested options before that expiration date or they will lapse and no longer be exercisable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
